- Acted for Bright Minds Biosciences Inc. in connection with its prospectus and listing on the Canadian Securities Exchange, 2021
- Acted for Bright Minds Biosciencess Inc. in an overnight marketed short form prospectus for gross proceeds of $25.9 million, March 2021
- Acted for Turmalina Metals Corp. in an overnight marketed prospectus offering for gross proceeds of $8,500,000, February 2020
- Acted for Turmalina Metals Corp. in connection with its prospectus and listing on the TSX Venture Exchange, 2019
- Acted for Aurora Cannabis Inc. in connection with its acquisition of Whistler Medical Marijuana Corporation valued at $175,000,000.
- Acted for Harvest One Cannabis Inc. (formerly Harvest One Capital Inc.) in its qualifying transaction involving the acquisition of 100% of the issued and outstanding shares of each of United Greeneries Holdings Ltd. from MMJ PhytoTech Limited and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly subsidiary of MMJ PhytoTech Limited, and a related brokered $25,000,000 subscription receipt offering
- Acts for various TSX Venture Exchange and Canadian Securities Exchange listed issuers in brokered and non-brokered debt and equity financings
- Acts for companies completing going public transactions including reverse takeovers on the TSX Venture Exchange and Canadian Securities Exchange
- Acts for Capital Pool Companies and businesses in completing “qualifying transactions” pursuant to the TSX Venture Exchange CPC program
- Acted for VMS Ventures Inc. while Royal Nickel Corporation was purchasing it for a total consideration of $21.1 million, April 2016



Sasa Jarvis*
Sasa Jarvis is a respected capital markets and securities lawyer. Her practice focuses primarily on corporate and securities law matters, where Sasa advises both private and public clients on a range of transactions. Her experience includes financings of public and private companies, initial public offerings, listings, mergers and acquisitions, and continuous disclosure obligations.
Representing clients in various industries, Sasa works extensively with clients in the mining and life sciences sectors. As part of her mining practice, Sasa advises public and private companies with respect to property option agreements, acquisitions of mineral properties, asset purchase and sale transactions, joint ventures, as well as technical disclosure.
Sasa’s life sciences practice includes providing advice to companies operating in highly regulated spaces, including cannabis and psychedelics, including on transactional and corporate compliance matters, going public transactions, raising funds, and continuing to comply with disclosure and other requirements. She has assisted clients in the cannabis space since the firm established its dedicated practice in 2016, and is a frequent writer and speaker on developments in Canadian law as they relate to psychedelic regulation.
Expertise
Representative Matters
Speaking Engagements
“Legislative Update”, Advanced Securities 2020 Series, Continuing Legal Education Society of British Columbia
June 2020News
Media Mentions
- “The new cannabis? – The drive towards allowing psychedelics such as magic mushrooms for some uses is gaining momentum“, by Luis Millàn, CBA/ABC National (September 27, 2021)
Directorships & Affiliations
- Past Co-Chair of SOGIC-BC, a section of the Canadian Bar Association in British Columbia
- Law Society of British Columbia
Education & Admissions
Publications
- “Canada’s growing psychedelics industry has reason to pay attention to B.C. decriminalization decision,” The Globe and Mail (July 2, 2022)
Insights (23 Posts)
Recent Updates in the Canadian Psychedelics Landscape
Psychedelics have come to be viewed as a potential therapeutic tool by the general public and government. This bulletin summarizes recent Canadian developments.
The Energy Statutes Amendment Act – Expansion of Liability for Officers and Directors in Energy Sector
British Columbia’s Energy Statutes Amendment Act expands the potential liabilities for oil and gas activities to directors and officers.
Don’t put your LIFE on the line: US Securities Law Considerations for the Listed Issuer Financing Exemption
Considerations for issuers who intend to use the Listed Issuer Financing Exemption in connection with an offer and sale of securities in the United States.
The Energy Statutes Amendment Act – British Columbia Welcomes the Hydrogen Industry
British Columbia’s Energy Statutes Amendment Act makes sweeping changes to the regulation of energy in British Columbia.
Canadian Securities Administrators Comment on Disclosure Related to Mineral Projects and Technical Reports
On November 3, 2022, the Canadian Securities Administrators published Staff Notice 51-364 Continuous Disclosure Review Program Activities for 2022 and 2021.
Mind the (Non-)GAAP: Review of Financial Measures Disclosure Under NI 52-112
An overview of the common deficiencies flagged by the CSA with respect to issuers' compliance with disclosure requirements under NI 52-112 and CP 52-112.
Government of Alberta to Regulate Health Care Practitioners Administering Psychedelics
Alberta is implementing a new framework for regulating and licensing health care providers in connection with administering psychedelics.
Foreign Investment in Canada: Minerals are Critical and Annual Report Released
The government’s approach to reviewing foreign investment is evolving, with an increased focus on national security concerns.
2022 Starts on a High – Updates in the Psychedelics Industry and a Look Back at 2021
Recent amendments to the Special Access Program and a look back to 2021 on developments affecting the psychedelics industry.
Proposed Changes to the Promotional Activity Disclosure Requirements: Instrument 51-519
An overview of the proposed Instrument 51-519 from the BC Securities Commission on promotional activity disclosure requirements.
The Canadian Capital Market is Psyched: An Update on the Growing Wave in the Psychedelics Industry
This bulletin provides an overview of the regulations surrounding psychedelics in Canada and psychedelics companies in the Canadian capital markets.
Exemption for Four Patients Opens Door Further for Therapeutic Use of Psilocybin
A legal update on psychedelics: four Canadians with late stage cancer receive approval to use psilocybin to treat
their end-of-life distress.
Psychedelics and Canada’s Regulatory Landscape
A primer on the emerging psychedelics industry and how it fits into Canada's legal framework.
Stop the Presses: Printing of Disclosure Documents May Be a Thing of the Past
A summary of the proposal by CSA to adopt an "access equals delivery" model for disclosure documents.
CSA Notes Inadequate Disclosure of Financial Interest in Cannabis M&A
Securities regulators provided guidance regarding disclosure of financial interests and conflicts of interest in Cannabis transactions
The Next Phase of Canadian Cannabis: What to Expect in 2019 and Beyond
On June 14, 2019, Health Canada unveiled its Final Regulations for New Cannabis Products
Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China
Divergent Regulatory Approaches to Cryptocurrency Offerings: Developments in Canada, the United States, and China
Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores
Ontario Government to Grow LCBO: Recreational Cannabis to be sold at Government Stores
McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators
McMillan Advises on First Initial Coin Offering Granted Exemptive Relief by Canadian Securities Regulators
Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer
Canadian Securities Administrators Propose New Prospectus Exemption for Resale of Securities of a Foreign Issuer
Compliant at this Time: Canada’s Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis
Compliant at this Time: Canada's Options Regarding its Treaty Obligations and the Legalization and Regulation of Non-Medical Cannabis
Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis
Prohibition to Go Up in Smoke: Government of Canada Introduces Legislation to Legalize and Regulate Non-Medical Access to Cannabis
Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions
Rights (offering) on the money: CSA announces changes to rights offering prospectus exemptions
Deals & Cases (4 Posts)
Emblem Corp. Completes Qualifying Transaction
Emblem Corp. was represented by a McMillan team led by Desmond Balakrishnan and included Barbara Collins, Arman Farahani, Mark Neighbor and Sasa Pudar (Capital Markets and M&A), Melanie Harmer (Litigation) assisting with court materials, and Michael Reid and Lindsay Dykstra (Business Law) assisting with due diligence.
Uranium Energy Corp closes US$10.51 million financing
Uranium Energy Corp closes US$10.51 million financing
Plentyoffish acquired for US$575 million by Match.com
Plentyoffish acquired for US$575 million by Match.com
Uranium Energy closes US$10M public offering
Uranium Energy closes US$10M public offering
Get updates delivered right to your inbox. You can unsubscribe at any time.